Company Overview of Sequus Pharmaceuticals, Inc.
Sequus Pharmaceuticals, Inc. manufactures, develops, and distributes pharmaceutical products to treat cancer and infectious diseases. The company develops and markets DOXIL®, an anticancer drug; and AMPHOTEC®, an antifungal drug in the United States. Sequus Pharmaceuticals, Inc. was formerly known as Liposome Technology, Inc. and changed its name to Sequus Pharmaceuticals, Inc. in June 1995. The company was founded in 1981 and is based in Menlo Park, California. As of March 17, 1999, Sequus Pharmaceuticals, Inc. operates as a subsidiary of ALZA Corporation.
960 Hamilton Court
Menlo Park, CA 94025
Founded in 1981
Key Executives for Sequus Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Par Pharmaceutical, Inc.||United States|
|Infusion Treatment Centers, Inc.||United States|
|Bruker Daltonics Inc.||United States|
|INC Research, LLC||United States|
|Mycogen Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Germany, PA | Life TechnologiesPosted: Nov 22
- Frederick, MD | Computer Sciences Corporation (CSC)Posted: Nov 26
- Spring House, PA | Johnson & JohnsonPosted: Dec 05
- Houston, TX | Baylor College of MedicinePosted: Dec 07
Sponsored Financial Commentaries
To contact Sequus Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.